Şirket hakkında

The Institute for Biomarker Research (IBR), a member of Genesis Biotechnology Group, was established in 2014 with the mission of developing molecular-based diagnostics and pharmacogenomic biomarkers in oncology, infectious disease and obstetrics and gynecology.

US
Bilinmeyen
Doğrulanmamış şirket